Description:

Trajenta is a prescription medication containing linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage blood sugar levels in adults with type 2 diabetes. It works by increasing the levels of natural substances that lower blood sugar, especially after meals. Trajenta is typically used alongside a healthy diet and exercise routine and may be combined with other diabetes medications.

Key Benefits:

• Blood Sugar Control: Helps regulate blood sugar levels in type 2 diabetes.
• Once-Daily Dose: Convenient single daily dose.
• Weight-Neutral: Typically does not cause weight gain.
• Combination Therapy: Can be used with other diabetes medications such as metformin or insulin for enhanced effect.

How It Works:

Linagliptin inhibits the enzyme DPP-4, which results in prolonged activity of incretin hormones. This leads to increased insulin release and decreased glucagon secretion, especially after meals, helping to control blood sugar levels.